Rocket Lab leads with reusable Neutron fairing, expands 500–1,000kg satellites, and grows higher-margin space systems revenue ...
Janux Therapeutics is now rated Hold after recent JANX007 Phase 1 data failed to show clear differentiation in mCRPC. Read my ...
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistan ...
On the third day of the 23XI Racing and Front Row Motorsports v NASCAR antitrust trial, testimony was concluded from ...
BETA Technologies, Inc. (NYSE:BETA) Q3 2025 Earnings Call Transcript December 5, 2025 Operator: Welcome to the Beta Technologies Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I ...
The 74 on MSN
What does AI readiness mean for schools?
Class Disrupted is an education podcast featuring author Michael Horn and Futre’s Diane Tavenner in conversation with ...
Perovskites are promising materials for solar cells. A layer of dipolar molecules at the perovskite surface improves the ...
As India ages, traditional diets aren't enough for optimal health after 50. Advances in nutrient delivery systems, like ...
Inside human cells, biology has pulled off the ultimate packing job, figuring out how to fit six feet of DNA into a nucleus ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Background CFTR modulators have transformed cystic fibrosis (CF) treatment, but individual responses vary even among patients with identical CFTR genotypes. This underscores the need for predictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback